Buy Generic Cardarone Online
|
|
Generic Cardarone 200mg
Package | Price | Per Pill | Shipping | Order | |
200mg x 30 pills | $62.02 | $2.07 | Add to Cart | ||
200mg x 60 pills | $117.05 | $1.95 | Add to Cart | ||
200mg x 90 pills | $169.89 | $1.89 | Add to Cart | ||
200mg x 120 pills | $222.71 | $1.85 | Free Airmail shipping |
Add to Cart |
Generic Cardarone Information
Introduction
Cardarone is a cardiovascular medication whose active ingredient is amiodarone, a class‑III anti‑arrhythmic agent. In the United Kingdom it is prescribed for the management of serious cardiac rhythm disturbances, most notably ventricular tachyarrhythmias and atrial fibrillation that are refractory to other treatments. The drug belongs to the cardiovascular therapeutic group and is supplied by manufacturers that produce generic amiodarone for international markets. Secondary uses include rate control in certain supraventricular arrhythmias, though these are off‑label in the UK.
What is Cardarone?
Cardarone is a solid oral formulation containing the active compound amiodarone. It is classified as an anti‑arrhythmic drug (Class III) that prolongs the cardiac action potential and refractory period. The product is manufactured by several licensed pharmaceutical firms that distribute generic amiodarone worldwide; specific branding varies by region. Well‑known brand‑name versions of amiodarone include Cordarone and Pacerone. Our online pharmacy provides this generic alternative as a cost‑effective treatment option for patients who need long‑term rhythm control.
How Cardarone Works
Amiodarone blocks multiple ion channels—including potassium, sodium, and calcium channels—while also exerting non‑competitive antagonism of α‑ and β‑adrenergic receptors. By prolonging phase 3 of the cardiac action potential, it increases the effective refractory period of myocardial tissue, thereby reducing the likelihood of premature depolarisation and re‑entry circuits. The drug’s high lipophilicity leads to extensive tissue distribution, resulting in a long elimination half‑life of roughly 50‑60 days. Therapeutic effects typically emerge after a loading phase of several days to weeks, reflecting the time needed for tissue accumulation.
Conditions Treated with Cardarone
- Ventricular tachycardia (VT) and ventricular fibrillation (VF) – These life‑threatening ventricular arrhythmias are the primary approved indications. Amiodarone’s ability to stabilise ventricular myocardium lowers the risk of sudden cardiac death.
- Atrial fibrillation (AF) and atrial flutter – When rate control or rhythm conversion fails with beta‑blockers, calcium channel blockers, or class I agents, amiodarone is employed to maintain sinus rhythm or control ventricular response.
- Supraventricular tachyarrhythmias (off‑label) – Certain atrial tachycardias, such as multifocal atrial tachycardia, may respond to amiodarone, though clinical guidance remains limited.
In the UK, atrial fibrillation affects an estimated 2 % of adults over 65 years, representing a major source of stroke and heart failure. Ventricular arrhythmias, though less common, account for a significant proportion of cardiac arrest events. Cardarone’s proven efficacy in clinical trials supports its role in reducing morbidity and mortality in these populations.
Who is Cardarone For?
Cardarone is suitable for adult patients who have been diagnosed with sustained ventricular arrhythmias or persistent atrial fibrillation that cannot be adequately managed with first‑line agents. Typical candidates include:
- Individuals with structural heart disease (ischaemic cardiomyopathy, post‑myocardial infarction) who require rhythm stabilization.
- Patients experiencing recurrent atrial fibrillation despite treatment with beta‑blockers, digoxin, or calcium channel blockers.
- Those undergoing cardiac surgery or electrophysiological procedures where prophylactic anti‑arrhythmic therapy is indicated.
Contra‑indications or cautionary scenarios include:
- Severe sinus node disease or advanced atrioventricular block without a pacemaker.
- Pre‑existing pulmonary fibrosis, severe thyroid disease, or liver dysfunction.
- Pregnancy, lactation, or known hypersensitivity to amiodarone.
Risks, Side Effects, and Interactions
Common
- Photosensitivity and skin discoloration – Patients often notice a blue‑grey hue to the skin after prolonged exposure to sunlight.
- Thyroid dysfunction – Both hypo‑ and hyper‑thyroidism can develop due to iodine excess; routine monitoring of TSH is recommended.
- Gastro‑intestinal upset – Nausea, constipation, and loss of appetite are frequently reported during the loading phase.
Rare
- Corneal micro‑deposits – Small, reversible deposits appear on the cornea; they rarely affect vision but may cause glare.
- Peripheral neuropathy – Sensory changes in the hands or feet have been described in long‑term therapy.
- Liver enzyme elevation – Hepatotoxicity is infrequent but warrants periodic liver function testing.
Serious
- Pulmonary toxicity – Interstitial pneumonitis and fibrosis can be life‑ threatening; symptoms include dyspnoea, dry cough, and fever. Immediate discontinuation and specialist assessment are required.
- Severe bradycardia or heart block – Excessive AV nodal inhibition may precipitate symptomatic bradycardia; pacemaker placement may be necessary.
- QT prolongation with torsades de pointes – Though rare, monitoring of the QT interval is essential, especially when combined with other QT‑prolonging drugs.
Drug–Drug Interactions
- Warfarin – Amiodarone potentiates anticoagulant effect; INR should be closely monitored.
- Digoxin – Increased plasma levels may lead to toxicity; dosage adjustments are often needed.
- Statins (especially simvastatin) – Enhanced risk of myopathy; dose reduction or alternative lipid‑lowering agents are advisable.
- Antibiotics (e.g., erythromycin, clarithromycin) – Combined QT‑prolonging potential warrants ECG surveillance.
Practical Use: Dosing, Missed Dose, Overdose
Standard dosing
- Loading phase: 800 mg (four 200 mg tablets) taken twice daily for 1–2 weeks, or 1,200 mg daily in divided doses for acute arrhythmia control.
- Maintenance phase: 100–200 mg once daily, adjusted according to clinical response and plasma levels.
Missed dose
If a dose is forgotten, take it as soon as remembered unless the next scheduled dose is within 8 hours. In that case, skip the missed dose and continue the regular dosing schedule; do not double the dose.
Overdose
Signs of amiodarone overdose include hypotension, severe bradycardia, heart block, and pulmonary distress. Immediate medical attention is mandatory. Treatment may involve intravenous fluids, atropine, or temporary pacing, depending on the clinical scenario.
Practical precautions
- Take Cardarone with food to minimise gastrointestinal irritation.
- Avoid excessive alcohol, as it may potentiate hepatic toxicity.
- Patients with renal impairment do not require dose reduction, but hepatic function should be assessed regularly.
- Regular ophthalmologic and pulmonary evaluations are advised for long‑term users.
Buying Cardarone from Our Online Pharmacy
Cardarone can be purchased securely from our online pharmacy in the UK. Our service offers:
- Affordable pricing – We source the generic product near manufacturer cost, passing savings directly to the patient.
- Verified quality – All stock originates from licensed overseas suppliers that meet European Good Manufacturing Practice (GMP) standards.
- Guaranteed delivery – Discreet packaging is dispatched with express service (≈ 7 days) or regular airmail (≈ 3 weeks), ensuring reliable receipt.
- Online‑only access – For patients who face limited availability through local pharmacies or insurance schemes, our pharmacy broker model connects you with international licensed pharmacies while preserving privacy.
Our pharmacy operates as a broker, collaborating with overseas licensed pharmacies to provide a confidential, cost‑effective route to essential medications such as Cardarone.
FAQ
-
Is Cardarone available in both brand‑name and generic forms in the UK?
Cardarone is supplied as a generic formulation of amiodarone. Brand‑name equivalents such as Cordarone or Pacerone are also marketed in the UK, but the generic version typically offers a lower price point while containing the identical active ingredient. -
What storage conditions are recommended for Cardarone tablets?
Store the tablets at controlled room temperature (15‑25 °C). Keep them away from direct sunlight, excess humidity, and heat sources. Do not refrigerate or freeze the medication. -
Can Cardarone be taken with food or should it be taken on an empty stomach?
Taking Cardarone with a meal reduces the risk of gastrointestinal irritation. The drug’s absorption is not significantly altered by food, so patients may choose to take it with or without a light snack according to tolerance. -
How does long‑term use of Cardarone affect the skin?
Prolonged therapy can cause a blue‑grey discoloration of the skin, especially in sun‑exposed areas, due to the drug’s photosensitising properties. Patients are advised to use sunscreen and protective clothing during outdoor activities. -
What monitoring is required for patients on Cardarone?
Regular assessments include thyroid function tests (TSH), liver enzymes, pulmonary function, and an annual ophthalmologic examination. ECG monitoring is essential during initiation and after dose changes. -
Is Cardarone compatible with contraceptive devices such as IUDs or hormonal pills?
Amiodarone does not interfere with the efficacy of intra‑uterine devices or hormonal contraceptives. However, patients should discuss all medications with their healthcare provider to rule out indirect interactions. -
Does Cardarone have any impact on drug testing for employment or sport?
Amiodarone is not a controlled substance and does not appear on standard drug panels for employment or anti‑doping tests. Nonetheless, its presence may be noted in comprehensive toxicology screens, so athletes should disclose use to relevant authorities. -
Are there any known differences in Cardarone formulation between regions such as the EU, US, and Asia?
While the active ingredient remains constant, excipients (inactive fillers, binders) may vary according to regional regulatory requirements. These differences are generally clinically insignificant but can affect tablet appearance or dissolution rate. -
Can Cardarone be safely imported for personal use in the UK?
Personal importation of prescription‑only medicines is permitted under UK law when the supply is for a single patient, the product is sourced from a licensed overseas pharmacy, and a valid prescription exists. Importing without a prescription may be restricted. -
What will happen if Cardarone is taken together with a warfarin anticoagulant?
Amiodarone can increase warfarin plasma concentrations, elevating the risk of bleeding. Patients should have their INR checked more frequently after initiating or adjusting Cardarone, and dosage modifications of warfarin may be required. -
Does Cardarone have any known interactions with over‑the‑counter cold remedies?
Some decongestants (e.g., pseudoephedrine) can raise blood pressure and heart rate, potentially counteracting the rate‑controlling effects of amiodarone. Caution is advised, and patients should consult a pharmacist before using OTC cold products. -
How long does it typically take for Cardarone to reach steady‑state concentrations in the body?
Due to its long half‑life, steady‑state levels are usually achieved after 4–6 weeks of consistent dosing. This delayed accumulation underlies the need for a loading phase to obtain therapeutic effects sooner.
Glossary
- Anti‑arrhythmic (Class III)
- A drug that prolongs the cardiac action potential by blocking potassium channels, thereby extending the refractory period and stabilising abnormal heart rhythms.
- Half‑life
- The time required for the plasma concentration of a drug to decrease by 50 %. Amiodarone’s half‑life is approximately 50‑60 days, leading to prolonged tissue exposure.
- Pulmonary toxicity
- Damage to lung tissue caused by drug exposure, presenting as inflammation, fibrosis, or reduced respiratory function.
⚠️ Disclaimer
The information provided about Cardarone is for general knowledge only. It does not replace professional medical consultation. All treatment decisions should be made under the supervision of a qualified healthcare provider. We assume all readers are responsible adults capable of making informed decisions about their health. Our online pharmacy offers access to Cardarone for individuals who may have limited availability through traditional pharmacies, prescription‑based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication.